Announcements Trials

Browse Landscape

Phase

Status

Terminated 4 Withdrawn 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 4 Docetaxel 3 pembrolizumab 2 Nivolumab 2 Etoposide 2 Carboplatin 2 osimertinib 1 icotinib 1 famitinib 1 durvalumab 1 decitabine and cedazuridine drug combination 1 dabrafenib 1 cemiplimab 1 alirocumab 1 aldesleukin 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy 1 Radiosurgery 1 Radionuclide Imaging 1 Radiation 1 Prednisone 1 Positron-Emission Tomography 1 Platinum 1 Pemetrexed 1 Panitumumab 1 Paclitaxel 1 Monatide (IMS 3015) 1 Methods 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × HM781-36B × Thoracic × Clear all

NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡